|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.00 USD | 0.00% |
|
0.00% | - |
| 08-07 | BlossomHill Therapeutics Shares Fall in Nasdaq Debut | MT |
| 08-07 | BlossomHill Therapeutics Prices Upsized Nasdaq IPO | MT |
| 1 week | 15.25 |  | 16.05 |
| 1 month | 15.25 | | 16.05 |
| Current year | 15.25 | | 16.05 |
| 1 year | 15.25 | | 16.05 |
| 3 years | 15.25 | | 16.05 |
| 5 years | 15.25 | | 16.05 |
| 10 years | 15.25 | | 16.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 31/05/2020 | |
Jason Keyes
DFI | Director of Finance/CFO | 55 | 30/04/2025 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 31/05/2020 | |
Bihua Chen
BRD | Director/Board Member | 57 | 31/01/2021 |
Yi Shan Li
CHM | Chairman | 61 | 31/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/08/26 | Cormorant Asset Management LP
| Other | Company | 3,301,534 | 15.5367% | |
| 06/08/26 | Other | Chief Financial Officer | 175,417 | 0.8255% | ||
| 06/08/26 | Other | Director | 589,195 | 2.7727% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -30.7M -26.55M -24.79M -22.75M -42.78M -2.92B -43.46M -291M -114M -1.46B -115M -113M -4.84B | -60.56M -52.38M -48.92M -44.87M -84.4M -5.76B -85.74M -574M -225M -2.89B -227M -222M -9.55B |
| Net Debt | - | - |
Employees
-
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | US$16.00 | 0.00% | 1,757,634 |
| 06/08/26 | US$16.00 | 0.00% | 0 |
- Stock Market
- Stocks
- BLSM Stock
Select your edition
All financial news and data tailored to specific country editions
